3537
SHOEI YAKUHIN CO.,LTD.
昭栄薬品
- Industry
- Wholesale Trade
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2022
21,147,821
Mar 2023
24,529,038
Mar 2024
22,595,830
Mar 2025
25,012,868
Mar 2026
26,921,663
Operating profit(thousand JPY)
Mar 2022
302,336
Mar 2023
488,215
Mar 2024
440,316
Mar 2025
559,832
Mar 2026
504,736
Operating profit margin(%)
Mar 2022
1.43
Mar 2023
1.99
Mar 2024
1.95
Mar 2025
2.24
Mar 2026
1.87
Profit before tax(thousand JPY)
Mar 2022
844,904
Mar 2023
673,545
Mar 2024
651,730
Mar 2025
757,557
Mar 2026
725,284
Profit(thousand JPY)
Mar 2022
578,640
Mar 2023
484,559
Mar 2024
491,913
Mar 2025
527,412
Mar 2026
557,061
Total assets(thousand JPY)
Mar 2022
14,480,863
Mar 2023
14,798,019
Mar 2024
16,815,943
Mar 2025
17,098,397
Mar 2026
17,806,225
Cash and cash equivalents(thousand JPY)
Mar 2022
913,365
Mar 2023
1,260,944
Mar 2024
1,901,887
Mar 2025
1,587,125
Mar 2026
1,452,563
Cash flows from operating activities(thousand JPY)
Mar 2022
-398,371
Mar 2023
644,570
Mar 2024
818,263
Mar 2025
-171,649
Mar 2026
103,528
Cash flows from investing activities(thousand JPY)
Mar 2022
382,729
Mar 2023
-30,110
Mar 2024
-18,433
Mar 2025
-21,013
Mar 2026
317,133
Cash flows from financing activities(thousand JPY)
Mar 2022
-62,477
Mar 2023
-269,324
Mar 2024
-172,143
Mar 2025
-129,273
Mar 2026
-583,024
Return on equity(%)
Mar 2022
7.9
Mar 2023
6.8
Mar 2024
6.3
Mar 2025
6.2
Mar 2026
6.1
Equity ratio(%)
Mar 2022
48
Mar 2023
49.8
Mar 2024
48.4
Mar 2025
52.3
Mar 2026
52.9
Earnings per share(JPY per share)
Mar 2022
167.29
Mar 2023
141.83
Mar 2024
144.75
Mar 2025
154.78
Mar 2026
162.92
Net assets per share(JPY per share)
Mar 2022
2,011.64
Mar 2023
2,172.26
Mar 2024
2,392.07
Mar 2025
2,619.85
Mar 2026
2,749.72
Dividend per share(JPY per share)
Mar 2022
42
Mar 2023
36
Mar 2024
38
Mar 2025
39
Mar 2026
46
Payout ratio(%)
Mar 2022
25.11
Mar 2023
25.38
Mar 2024
26.25
Mar 2025
25.2
Mar 2026
28.23
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.